Revolution Medicines/$RVMD
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Revolution Medicines
Revolution Medicines Inc is a clinical-stage precision oncology company developing novel targeted therapies for RAS-addicted cancers. The Company possesses structure-based drug discovery capabilities built upon chemical biology and cancer pharmacology know-how and proprietary technologies that enable the creation of small molecules tailored to unconventional binding sites. Its research and development pipeline comprises inhibitors that bind directly to RAS variants (RAS(ON) Inhibitors), designed to be used as monotherapy, in combination with other RAS(ON) Inhibitors and/or other therapeutic agents.
Ticker
$RVMD
Sector
Primary listing
Employees
883
Headquarters
Website
RVMD Metrics
BasicAdvanced
$19B
-
-$5.95
1.01
-
Price and volume
Market cap
$19B
Beta
1.01
52-week high
$124.49
52-week low
$29.17
Average daily volume
2.2M
Financial strength
Current ratio
7.145
Quick ratio
6.975
Long term debt to equity
25.175
Total debt to equity
26.185
Interest coverage (TTM)
-48.80%
Profitability
EBITDA (TTM)
-1,174.619
Management effectiveness
Return on assets (TTM)
-30.08%
Return on equity (TTM)
-58.07%
Valuation
Price to book
11.46
Price to tangible book (TTM)
11.97
Price to free cash flow (TTM)
-19.738
Free cash flow yield (TTM)
-5.07%
Free cash flow per share (TTM)
-4.806
Growth
Earnings per share change (TTM)
66.32%
3-year earnings per share growth (CAGR)
24.48%
What the Analysts think about RVMD
Analyst ratings (Buy, Hold, Sell) for Revolution Medicines stock.
RVMD Financial Performance
Revenues and expenses
RVMD Earnings Performance
Company profitability
RVMD News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Revolution Medicines stock?
Revolution Medicines (RVMD) has a market cap of $19B as of March 16, 2026.
What is the P/E ratio for Revolution Medicines stock?
The price to earnings (P/E) ratio for Revolution Medicines (RVMD) stock is 0 as of March 16, 2026.
Does Revolution Medicines stock pay dividends?
No, Revolution Medicines (RVMD) stock does not pay dividends to its shareholders as of March 16, 2026.
When is the next Revolution Medicines dividend payment date?
Revolution Medicines (RVMD) stock does not pay dividends to its shareholders.
What is the beta indicator for Revolution Medicines?
Revolution Medicines (RVMD) has a beta rating of 1.01. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.